Characteristics of Early Sacubitril/Valsartan Users in a Managed Care Population with Heart Failure to Inform Future Outcomes Studies
Poster presented at International Society of Pharmacoeconomics and Outcomes Research's Annual International Meeting, May 20 - May 24, 2017 in Boston, MA, US .
Author(s):
Yiqiong Xie, Lauren E Parlett
, Aliza Gordon, Gosia Sylwestrzak, John Barron
Presenting author: Yiqiong Xie
Abstract
The uptake of the new sacubitril/valsartan medication has been slow, but on a gradual rise. The real-world sacubitril/valsartan users in a managed care population are complicated patients with significant medical comorbidities and a history of taking heart failure medication. Understanding the characteristics of this population will inform comparator selection in future studies.
Funding Transparency
This work was possible through:
- No Funding Sought or Awarded
Tags
Analytic: descriptive | univariate
Data Source: claims
Research Focus: characteristics
Study Design: cross-sectional
Entry last updated (DMY): 26-11-2024.